Investor & Corporate Presentations Date Title Topline Results for Phase 2 Clinical Trial of OTX-DED for the Short-term Treatment of Dry Eye Disease Presentation 12/6/21 Corporate Presentation – November 2021 11/16/21 HC Wainwright Global Conference 2021 Presentation 9/13/21 Berenberg Presentation – April 2021 4/29/21 Topline Data: Dextenza For the Treatment of Allergic Conjunctivitis 4/28/20
Topline Results for Phase 2 Clinical Trial of OTX-DED for the Short-term Treatment of Dry Eye Disease Presentation 12/6/21
